FindTrial
Sign In

A study to evaluate quality of life (QOL) in patients diagnosed with cancer stituated deep inside abdominal cavity and who underwent complex surgeries involving multiple abdominal organs and blood vessels.

To evaluate quality of life (QOL) in patients undergoing multivisceral resections and/or vascular resections for retroperitoneal sarcomas. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/08/093492
Enrollment
100
Registered
2025-08-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C480- Malignant neoplasm of retroperitoneum

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Tata Memorial Hospital, Mumbai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients who can be contacted in person or telephonically 2. All patients over 18-years of age, undergoing Multi-visceral resections for RP sarcomas 3. All patients undergoing Vascular resection (with/ without reconstructions) for RP sarcomas

Exclusion criteria

Exclusion criteria: 1.Other RP tumors (non-sarcomas) 2.Patients not willing to participate in the study/ cannot give a valid informed consent

Design outcomes

Primary

MeasureTime frame
To evaluate Long-term ( more than 8 weeks) QOL in patients undergoing multivisceral and/or vascular resections for RP sarcomasTimepoint: day 0 on the day of enrollment, 3 months and 6 months after enrollment—

Secondary

MeasureTime frame
To evaluate short-term outcomes (less than 8 weeks) as Post op morbidity, Post-op Ileus, Acute renal failure, Diarrhoea, Clinically significant chyle leaks, Limb weakness, Lower limb edema , Length of ICU stay, ICU re-admission rates, Length of hospital stay, Hospital readmission rates, Re-operation rates, Fitness for adjuvant chemoTimepoint: day 0 on the day of enrollment, 3 months and 6 months after enrollment—

Countries

India

Contacts

Public ContactDr Akhila Mamidigi

Tata Memorial Hospital, Mumbai-12

drmaheshgoel@gmail.com9820504492

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026